Exploring the viability of Zeatin as a prospective therapeutic candidate for investigating the complex interplay between severe acute respiratory syndrome coronavirus (SARS-CoV) and Alzheimer’s disease
Crossref DOI link: https://doi.org/10.1007/s40203-024-00195-3
Published Online: 2024-03-28
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sriranjini, A. S.
Thapliyal, Ashish
Pant, Kumud
Text and Data Mining valid from 2024-03-28
Version of Record valid from 2024-03-28
Article History
Received: 25 August 2023
Accepted: 7 February 2024
First Online: 28 March 2024
Declarations
:
: The authors declare no competing interests.